****************Institutional flows & RVI liquidity concerns — early deployments + $600M raise (Stripe, ElevenLabs) + $1.5B buyback + CFO RSU + FY strength + SpaceX snub + stock rebound + Q1'26 earnings Apr28 + minor trims + insider sells****************
Key Questions
When is Robinhood's Q1 2026 earnings report scheduled?
Robinhood Markets will report Q1 2026 earnings on April 28, 2026, after market close, followed by a conference call at 5 PM ET. Consensus estimates call for $1.24B in revenue and $0.50 EPS, with Zacks ranking it #4 Sell and an EPS cut to $2.26.
What was Robinhood's FY 2025 revenue performance?
Robinhood achieved 52% year-over-year revenue growth in FY 2025, reaching $4.5B out of a $63B total platform metric. This reflects strong FY strength amid growth recaps.
How has Robinhood's stock price performed recently?
On April 9, the stock fell 3.2% to a low of $66.62 before rebounding with a prior +1.92% gain to $70.22, closing at $69.65. Technicals show RSI at 41 and IV at 77, indicating oversold conditions.
What recent analyst price target changes have occurred for Robinhood?
Analysts made minor trims, including Jefferies from $88 to $84 and Needham from $100 to $90, while consensus holds at $151 with a Moderate Buy rating and Piper at $155. The ABR is 1.61, signaling bullish sentiment.
Have Robinhood insiders been selling shares recently?
Insiders appear bearish, with Director Tenenov planning to sell $25.8M in stock per Form 144 and Vlad also involved in sales. This is viewed as a potential bearish signal.
Which institutions have recently invested in Robinhood?
Rheos Capital Works invested $19.79M in Q4, and Ark Invest added 182k shares worth $12.7M at $69.65. Institutional flows are mixed overall.
What is Robinhood's share buyback program?
Robinhood announced a $1.5B buyback alongside projections of $3.1B EBITDA and $3.25B at JPM. This supports shareholder value amid FY strength.
What is the recent performance of Robinhood Ventures Index (RVI)?
RVI has risen 37% since its debut, rebounding amid liquidity concerns with mega IPOs. Early deployments and raises like $600M from Stripe and ElevenLabs are noted in context.
FY'25 +52% $4.5B/$63B; Q1'26 Apr28 after close/5PM call cons $1.24B rev/$0.50 EPS (Zacks #4 Sell/EPS cut to $2.26)/$3.1B EBITDA/$1.5B buyback/$3.25B JPM; ABR 1.61 bullish; stock Apr9 -3.2% $67.55 low $66.62 +prior +1.92% $70.22 (RSI41/IV77 oversold)/$69.65; trims (Jefferies $88>84/Needham $100>90 etc.) cons $151 Mod Buy/Piper $155; insiders bearish (Tenenov $25.8M + Vlad); Rheos $19.79M Q4 + Ark 182k sh $12.7M $69.65; RVI +37%; Kalshi Apr16 risk; mixed insti; recaps echo growth/vol/NII caution.